Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06520787

DAta-driven personaLIzation of a digitAl Health Solution to Support Family Caregivers of Children With Chronic Conditions

Status
Recruiting
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Adhera Health, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The goal of this feasibility study is to explore the needs of families with children with obesity and evaluate the impact of a combined intervention (children with obesity receiving pharmacological therapy in combination with the Adhera Caring Digital Program®) on treatment satisfaction, adherence, and mood. The main objectives are: * To evaluate the impact of the treatment combination (ACDP® and pharmacological treatment) in terms of satisfaction, engagement, adherence and mood, in families with children with obesity. * To better understand the educational and support needs of the families of children with obesity while under treatment and lifestyle changes. Participants will: * Use the Adhera Caring Digital Program® (ACDP®) for obesity, which includes digital therapeutic software, personalized messages, and educational materials. * Take pharmacological treatment as prescribed for one year. * Wear activity wristbands/watches to collect biometric data. * Attend monthly clinic visits for assessments and monitoring. * Complete psychometric questionnaires to measure satisfaction, adherence, and emotional outcomes. * Engage in chat-based communication and video conferencing with health coaches for support and monitoring.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTACDP® and pharmacological treatment for obesity40 Families of children with obesity that are already undergoing treatment and are willing to join a combined intervention. After the recruitment, the family will join Adhera Caring Digital Program® for 10 months. The combined intervention (digital and pharmacological intervention) will last one year, and there will be a 2-month follow-up. During the whole study (12 months, from recruiting to the end of follow-up) participants will wear a smartwatch (Fitbit or similar).

Timeline

Start date
2025-03-11
Primary completion
2026-04-01
Completion
2026-05-01
First posted
2024-07-25
Last updated
2025-12-01

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06520787. Inclusion in this directory is not an endorsement.